We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Serologic Tests for Threadworm Infection Compared for Accuracy

By LabMedica International staff writers
Posted on 10 Feb 2014
The diagnosis of Strongyloides stercoralis or threadworm infection is hampered by the suboptimal sensitivity of fecal-based tests.

There are several serological methods that are believed to be more sensitive than microscopy, although assessing their accuracy is difficult because of the lack of sensitivity of a fecal-based reference gold standard.

Microbiologists at the Sacro Cuore Hospital (Negra Verona, Italy) and their colleagues assessed the sensitivity and specificity of five serologic tests for S. More...
stercoralis, three in-house and two commercially available, on 399 cryopreserved serum samples. Accuracy was measured using fecal results as the primary reference standard, but also using a composite reference standard based on a combination of tests.

The primary reference standard was direct detection of S. stercoralis larvae in stool, either through microscopy of at least three fecal samples after formol-ether concentration or Baermann, or stool agar/charcoal culture for S. stercoralis. Index serologic tests included three noncommercial tests: immunofluorescence antibody test (IFAT), recombinant Strongyloides antigen (NIE) enzyme-linked immunosorbent assay (NIE-ELISA) and the NIE- luciferase immunoprecipitation systems (NIE-LIPS). The two commercially available tests were the Bordier ELISA (Bordier Affinity Products; Crissier, Switzerland) and the SeroELISA Strongyloides IgG (IVD-ELISA) (IVD Research; Carlsbad, CA, USA).

The most sensitive test was IFAT, with 94.6% sensitivity, followed by IVD-ELISA with 92.3% sensitivity. The most specific test was NIE-LIPS, with specificity at 99.6%, followed by IVD-ELISA at 97.4%. NIE-LIPS did not cross-react with any of the specimens from subjects with other parasitic infections. NIE-LIPS and the two commercial ELISAs approach 100% specificity at a cut off level that maintains equal to or greater than 70% sensitivity.

The authors concluded that NIE-LIPS is the most accurate serologic test for the diagnosis of S. stercoralis infection. IFAT and each of the ELISA tests are sufficiently accurate, above a given cut off, for diagnosis, prevalence studies, and inclusion in clinical trials. IFAT loses sensitivity when gaining specificity at the optimal cut off for inclusion with a titer 1/160. The two commercially available ELISA tests showed reliable results in terms of accuracy and can also be used for inclusion in trials. The study was published on January 9, 2014, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Sacro Cuore Hospital
Bordier Affinity Products 
IVD Research



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
New
Amoebiasis Test
ELI.H.A Amoeba
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.